nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Topotecan—peripheral nervous system neoplasm	0.101	0.145	CbGbCtD
Rabeprazole—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0864	0.124	CbGbCtD
Rabeprazole—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0743	0.107	CbGbCtD
Rabeprazole—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0698	0.1	CbGbCtD
Rabeprazole—ABCG2—Vincristine—peripheral nervous system neoplasm	0.043	0.0618	CbGbCtD
Rabeprazole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0415	0.0597	CbGbCtD
Rabeprazole—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0401	0.0576	CbGbCtD
Rabeprazole—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0394	0.0566	CbGbCtD
Rabeprazole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0348	0.05	CbGbCtD
Rabeprazole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0332	0.0477	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0269	0.0386	CbGbCtD
Rabeprazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0217	0.0313	CbGbCtD
Rabeprazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0202	0.0291	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0162	0.0234	CbGbCtD
Rabeprazole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0149	0.0214	CbGbCtD
Rabeprazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00928	0.0134	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00912	0.0131	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00851	0.0122	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0058	0.00834	CbGbCtD
Rabeprazole—Pantoprazole—ABCB1—peripheral nervous system neoplasm	0.000975	0.391	CrCbGaD
Rabeprazole—Omeprazole—ABCB1—peripheral nervous system neoplasm	0.000795	0.318	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—peripheral nervous system neoplasm	0.000727	0.291	CrCbGaD
Rabeprazole—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000102	0.000339	CcSEcCtD
Rabeprazole—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000338	CcSEcCtD
Rabeprazole—Pain—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000338	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000337	CcSEcCtD
Rabeprazole—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000334	CcSEcCtD
Rabeprazole—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000334	CcSEcCtD
Rabeprazole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000333	CcSEcCtD
Rabeprazole—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000333	CcSEcCtD
Rabeprazole—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000331	CcSEcCtD
Rabeprazole—Asthma—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000331	CcSEcCtD
Rabeprazole—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.00033	CcSEcCtD
Rabeprazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.96e-05	0.00033	CcSEcCtD
Rabeprazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.93e-05	0.000328	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000326	CcSEcCtD
Rabeprazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.85e-05	0.000326	CcSEcCtD
Rabeprazole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.84e-05	0.000325	CcSEcCtD
Rabeprazole—Weight increased—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000325	CcSEcCtD
Rabeprazole—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000324	CcSEcCtD
Rabeprazole—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000323	CcSEcCtD
Rabeprazole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.77e-05	0.000323	CcSEcCtD
Rabeprazole—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000322	CcSEcCtD
Rabeprazole—Somnolence—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.000322	CcSEcCtD
Rabeprazole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000322	CcSEcCtD
Rabeprazole—Asthenia—Vincristine—peripheral nervous system neoplasm	9.7e-05	0.000321	CcSEcCtD
Rabeprazole—Pneumonia—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.00032	CcSEcCtD
Rabeprazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.62e-05	0.000318	CcSEcCtD
Rabeprazole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000318	CcSEcCtD
Rabeprazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.6e-05	0.000318	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000316	CcSEcCtD
Rabeprazole—Rash—Dactinomycin—peripheral nervous system neoplasm	9.54e-05	0.000316	CcSEcCtD
Rabeprazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.52e-05	0.000315	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000314	CcSEcCtD
Rabeprazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.45e-05	0.000313	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000312	CcSEcCtD
Rabeprazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.00031	CcSEcCtD
Rabeprazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.00031	CcSEcCtD
Rabeprazole—Pain—Etoposide—peripheral nervous system neoplasm	9.37e-05	0.00031	CcSEcCtD
Rabeprazole—Constipation—Etoposide—peripheral nervous system neoplasm	9.37e-05	0.00031	CcSEcCtD
Rabeprazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.00031	CcSEcCtD
Rabeprazole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.00031	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000309	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000309	CcSEcCtD
Rabeprazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.28e-05	0.000307	CcSEcCtD
Rabeprazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.25e-05	0.000306	CcSEcCtD
Rabeprazole—Sweating—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000305	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000305	CcSEcCtD
Rabeprazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000304	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000302	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000301	CcSEcCtD
Rabeprazole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.0003	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000299	CcSEcCtD
Rabeprazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000299	CcSEcCtD
Rabeprazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.03e-05	0.000299	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000298	CcSEcCtD
Rabeprazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.99e-05	0.000297	CcSEcCtD
Rabeprazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000297	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000296	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.96e-05	0.000296	CcSEcCtD
Rabeprazole—Dizziness—Vincristine—peripheral nervous system neoplasm	8.94e-05	0.000296	CcSEcCtD
Rabeprazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.92e-05	0.000295	CcSEcCtD
Rabeprazole—Rash—Alitretinoin—peripheral nervous system neoplasm	8.85e-05	0.000293	CcSEcCtD
Rabeprazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.84e-05	0.000292	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000292	CcSEcCtD
Rabeprazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.81e-05	0.000291	CcSEcCtD
Rabeprazole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000291	CcSEcCtD
Rabeprazole—Headache—Alitretinoin—peripheral nervous system neoplasm	8.79e-05	0.000291	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.73e-05	0.000289	CcSEcCtD
Rabeprazole—Urticaria—Etoposide—peripheral nervous system neoplasm	8.7e-05	0.000288	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000287	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000287	CcSEcCtD
Rabeprazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.67e-05	0.000287	CcSEcCtD
Rabeprazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.66e-05	0.000286	CcSEcCtD
Rabeprazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.66e-05	0.000286	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000286	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000286	CcSEcCtD
Rabeprazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000286	CcSEcCtD
Rabeprazole—Vomiting—Vincristine—peripheral nervous system neoplasm	8.6e-05	0.000284	CcSEcCtD
Rabeprazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.58e-05	0.000284	CcSEcCtD
Rabeprazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.000284	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000283	CcSEcCtD
Rabeprazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000282	CcSEcCtD
Rabeprazole—Rash—Vincristine—peripheral nervous system neoplasm	8.53e-05	0.000282	CcSEcCtD
Rabeprazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.52e-05	0.000282	CcSEcCtD
Rabeprazole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000282	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000281	CcSEcCtD
Rabeprazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.00028	CcSEcCtD
Rabeprazole—Headache—Vincristine—peripheral nervous system neoplasm	8.47e-05	0.00028	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000278	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000276	CcSEcCtD
Rabeprazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.34e-05	0.000276	CcSEcCtD
Rabeprazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000276	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000275	CcSEcCtD
Rabeprazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.18e-05	0.000271	CcSEcCtD
Rabeprazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.00027	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000269	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000267	CcSEcCtD
Rabeprazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.07e-05	0.000267	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000267	CcSEcCtD
Rabeprazole—Nausea—Vincristine—peripheral nervous system neoplasm	8.03e-05	0.000266	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000265	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8e-05	0.000265	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000263	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000261	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000261	CcSEcCtD
Rabeprazole—Asthenia—Etoposide—peripheral nervous system neoplasm	7.86e-05	0.00026	CcSEcCtD
Rabeprazole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000259	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000259	CcSEcCtD
Rabeprazole—Chills—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000257	CcSEcCtD
Rabeprazole—Pruritus—Etoposide—peripheral nervous system neoplasm	7.75e-05	0.000256	CcSEcCtD
Rabeprazole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000255	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000255	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000253	CcSEcCtD
Rabeprazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.6e-05	0.000251	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.00025	CcSEcCtD
Rabeprazole—Rash—Cisplatin—peripheral nervous system neoplasm	7.54e-05	0.000249	CcSEcCtD
Rabeprazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.53e-05	0.000249	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000249	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000249	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000248	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000247	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000247	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000245	CcSEcCtD
Rabeprazole—Tension—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000244	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000244	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.000242	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000241	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.00024	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—peripheral nervous system neoplasm	7.24e-05	0.00024	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000239	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000237	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000236	CcSEcCtD
Rabeprazole—Nausea—Cisplatin—peripheral nervous system neoplasm	7.1e-05	0.000235	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000235	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000234	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000231	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—peripheral nervous system neoplasm	6.97e-05	0.00023	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.00023	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.00023	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.00023	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000229	CcSEcCtD
Rabeprazole—Rash—Etoposide—peripheral nervous system neoplasm	6.91e-05	0.000228	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.9e-05	0.000228	CcSEcCtD
Rabeprazole—Headache—Etoposide—peripheral nervous system neoplasm	6.86e-05	0.000227	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000227	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000226	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000226	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000224	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000224	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000224	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000223	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000223	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000223	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000221	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.00022	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000219	CcSEcCtD
Rabeprazole—Cough—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000217	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000217	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000216	CcSEcCtD
Rabeprazole—Nausea—Etoposide—peripheral nervous system neoplasm	6.51e-05	0.000215	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000215	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000214	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000213	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000212	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000212	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000212	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000212	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000211	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000209	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000208	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000207	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000207	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000207	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000206	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000205	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000204	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000203	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000203	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000202	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000201	CcSEcCtD
Rabeprazole—Shock—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.0002	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.0002	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000199	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000199	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000198	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000196	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000196	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000196	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000196	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000195	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000194	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000194	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000192	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.00019	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.00019	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000188	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000188	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000185	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000185	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000184	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000184	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000183	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000182	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000182	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000181	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000181	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000179	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000179	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000177	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000176	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000174	CcSEcCtD
Rabeprazole—Pain—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000174	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000171	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.00017	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000169	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000168	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000167	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000167	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000166	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000165	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000163	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000161	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000161	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000161	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000161	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000161	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000155	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000154	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.00015	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000149	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000149	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000149	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000146	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000144	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000139	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000138	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000135	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000134	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000133	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000129	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000129	CcSEcCtD
Rabeprazole—Rash—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000128	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000128	CcSEcCtD
Rabeprazole—Headache—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000127	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000124	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000121	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000119	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000119	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000118	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000118	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000112	CcSEcCtD
